Filing Details
- Accession Number:
- 0001447362-24-000135
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-14 16:53:14
- Reporting Period:
- 2024-08-12
- Accepted Time:
- 2024-08-14 16:53:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236397 | Daniel Bradbury | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Suite 401 Friendswood TX 77546 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-12 | 5,021 | $26.65 | 30,102 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2024-08-12 | 1,431 | $26.65 | 8,550 | No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| Common Stock | Disposition | 2024-08-12 | 1,431 | $26.65 | 8,550 | No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrecovable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrecovable Descendant's Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,291 | Indirect | The Bradbury Family Trust |
Footnotes
- The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024.
- This transaction was executed in multiple trades at prices ranging from $26.31 to $27.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
- Held by Daniel Bradbury Irrecovable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
- Held by Annette Bradbury Irrecovable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
- Held by Bradbury Family Trust of which the Reporting Person and Annette Bradbury are the trustees and the beneficiaries. Reflects the transfer on June 6, 2024 of 13,291 shares of common stock from the Reporting Person's direct holdings to the Bradbury Family Trust.
Billionaire Hedge Funds
